CytomX Therapeutics, Inc. (CTMX) free cash flow

Free cash flow · fiscal 2025
-$75.81M

CytomX Therapeutics, Inc. (CTMX) generated free cash flow of -$75.81M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$86.54M. Figures as of 18 Nov 2026, 11:31 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
-$75.81M
Highest on record
$168.81Mfiscal 2017
Lowest on record
-$143.98Mfiscal 2019
Fiscal years on record
132013–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

CytomX Therapeutics, Inc. free cash flow, in more detail

Across the 13 fiscal years on record (2013–2025), the highest was $168.81M in fiscal 2017 and the lowest -$143.98M in fiscal 2019.

History · 13 fiscal years

Free cash flow by fiscal year

CytomX Therapeutics, Inc. free cash flow, year by year

CytomX Therapeutics, Inc. (CTMX) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025-$75.81M—
2024-$86.54M—
2023-$56.88M—
2022-$112.53M—
2021-$120.64M 4,189.5% down
2020$2.95M—
2019-$143.98M—
2018-$79.31M 147.0% down
2017$168.81M—
2016-$4.21M—
2015-$29.01M 196.3% down
2014$30.14M—
2013-$8.74M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

More on CTMX

CytomX Therapeutics, Inc., figure by figure

CytomX Therapeutics, Inc. (CTMX) overview: price, valuation and scorecard

CytomX Therapeutics, Inc. free cash flow: questions and answers

What is CytomX Therapeutics, Inc.'s free cash flow?

CytomX Therapeutics, Inc. (CTMX) generated free cash flow of -$75.81M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$86.54M.

What are the highest and lowest free cash flow figures on record for CytomX Therapeutics, Inc.?

Across the 13 fiscal years on record (2013–2025), the highest was $168.81M in fiscal 2017 and the lowest -$143.98M in fiscal 2019.

How is CytomX Therapeutics, Inc.'s free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For CytomX Therapeutics, Inc. it is on record here for 13 fiscal years, 2013 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “CytomX Therapeutics, Inc. (CTMX) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/CTMX/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.